The FCA has recently fined Sir Christopher Gent, former non-executive Chairman of a global medical products and technologies company (the Company), £80,000 for the unlawful disclosure of inside information relating to the Company in contravention of the EU Market Abuse Regulation (EU MAR). The published decision contains a number of key takeaways in relation to the identification and handling of inside information and acts a reminder that the FCA is motivated to take enforcement action in respect of improper disclosure, especially given the risk that breaches in this area pose to investor confidence and the integrity of the financial markets. We have drafted a briefing note on the decision which you can find here.